Clinical outcomes in patients with persistent atrial fibrillation after technologic advances including contact force‑guided and ablation index‑guided ablation
10.1186/s42444-022-00064-0
- Author:
Won Kyeong JEON
1
;
So‑Ryoung LEE
;
Eue‑Keun CHOI
;
Seil OH
Author Information
1. Department of Internal Medicine, Seoul National University Hospital, 101 Daehak‑ro, Jongno‑gu, Seoul 03080, Republic of Korea
- Publication Type:RESEARCH
- From:International Journal of Arrhythmia
2022;23(2):13-
- CountryRepublic of Korea
- Language:English
-
Abstract:
Purpose:We aimed to evaluate the influence of technological advances on ablation outcomes in patients with persistent atrial fibrillation (AF) (PeAF). Radiofrequency ablation for patients with AF has advanced, including contact force (CF)-sensing catheters and the ablation index (AI).
Methods:Between 2009 and 2018, we analyzed 173 patients with PeAF who underwent catheter ablation. We cat‑ egorized them into three groups: AF ablation without CF and AI information (no-CF group, n = 63), with CF without AI (CF-only group, n = 49), and with optimal AI-guided ablation (AI group, n = 61). Early (within 3 months, ER) and late (from 3 months to 1 year, LR) AF recurrence after ablation was assessed. Procedure-related complications were also evaluated.
Results:The baseline characteristics were similar among the 3 groups, excluding the baseline antiarrhythmic drug history. Additional substrate modification after pulmonary vein isolation was significantly low in frequency in the AI group (71.4%, no-CF; 69.4%, CF-only; 41.0%, AI, p = 0.001). The AI group had a shorter mean procedure-related time than the other groups. Both ER and LR of PeAF showed a trend of reduction with technological advances. With a short experience (less than 1 year), the CF-only group showed more ER and LR than that shown by the AI group. However, with a long experience (more than 1 year), ER and LR occurred similarly in the two groups. Procedure-related compli‑ cations improved with technological advances.
Conclusion:As ablation technology advanced, favorable clinical outcomes with short procedural times were observed. However, prospective, large multicenter studies are needed to verify these results.
